Bixiye
P16-23 New Reimbursement Policy: Skilled Nursing Services in the Home, Effective May 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2023
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1751 - 1760 ee natiijooyinka 3167
Bixiye
P69R1-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective January 2, 2023
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2023
Bixiye
2023 March Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2023
Bixiye
P11-23 Present on Admission Code Required for Hospital Acquired Condition Diagnoses
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2023
Bixiye
P69-22 New Medical, Medical Drug, and Behavioral Health Policy Management Updates Effective January 2, 2023
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2023
Bixiye
QP112R1-20 Changes to Electronic Funds Transfer Processes
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP11-23 Commercial Pharmacy Benefit Exclusion for Cimzia®
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP12-23 Change in Prior Authorization Process for Experimental or Investigative Services
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP6-23 Commercial Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Rebyota™, and Sunlenca® Injection
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2023
Bixiye
QP7-23 MHCP Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Lunsumio™, Rebyota™, Sunlenca® Injection, and Vivimusta
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2023